← All claims

Supplements

quercetin causes kidney injury

In plain terms: Is quercetin bad for your kidneys?

Refuted Supplements 🐭 Non-human evidence🔬 Includes disconfirming

Part of: 🧪 quercetin

RefutedContestedStrong support
consensus score -0.86

The evidence runs the other way: across sixteen studies quercetin protected kidneys from other damage rather than causing harm. The lone injury signal used injected, not oral, doses in rodents. What is genuinely missing is a proper human high-dose safety trial.

📅 Last reviewed: 2026-07-26 ⓘ

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: Animal studies (Animal)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

1 support 18 contradict 0 tested null 0 mixed · 19 sources, 19 independent groups

What the evidence shows

This one runs the opposite way to the worry. Across seventeen studies, sixteen tested quercetin as a RESCUE agent against kidney damage from something else — cisplatin, radiation, vancomycin, diclofenac, iron overload, ischaemia-reperfusion, diabetic nephropathy — and in every case it REDUCED injury markers rather than causing them.

The evidence (19)

SourceGradeStanceQualityFinding
Chen H, Zhan Z, Lu M, Li D, Peng J, Chen L, Yi B, Huang Z
2026 · Ecotoxicology and environmental safety
in-vitro contradicts low In PM2.5-exposed HK-2 human kidney tubule cells, quercetin treatment (like FOXP1 overexpression) mitigated PM2.5-induced cellular senescence via the FOXP1/p21 pathway. In-vitro protective effect of quercetin against particulate-matter-induc
Zhao F, Zhou X, Chen J, Li R, Sun Y, Zhou J, Li H, Zheng G, Zhu L
2026 · Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
in-vitro contradicts low In HK-2 human kidney cells, quercetin (flagged by network-toxicology/docking as a candidate antagonist) reduced diclofenac-induced inflammatory cytokine secretion and reversed diclofenac-induced dysregulation of injury-associated proteins (
Elsherbiny MA, Bishr A, Sherif MM, Awad AS
2026 · The Journal of pharmacy and pharmacology
animal contradicts moderate Rats given quercetin 50 or 100 mg/kg for 10 days before bilateral renal ischaemia-reperfusion surgery showed preserved kidney function, higher SOD/SLC7A11, and suppressed NF-kB/TNF-a and p53/apoptotic pathways (via SIRT-1 activation) versus
Hamad NS, Ghafoor DD, Rasul HO
2026 · Scientific reports
animal supports moderate Healthy female Wistar rats given intraperitoneal quercetin (5, 10, 20, or 30 mg/kg every 72h for 21 days): doses >=20 mg/kg reduced weight gain and increased kidney/liver/spleen relative weight with dose-related histopathological lesions in
Onaolapo A et al
2026 · Research Square
animal contradicts low Wistar rats fed a high-fat/high-sugar diet developed renal (and hepatic) histopathological damage plus elevated urea/creatinine; co-treatment with quercetin 100 or 200 mg/kg partially restored renal histoarchitecture and improved these mark
El-Hady AMA, Azzoz RM, Soliman SM, Khalil WM, Ali SA
2026 · Scientific reports
animal contradicts moderate Male rats given oral quercetin 1.25 g/kg/day (very high rodent dose, 4wk course) plus curcumin before whole-body gamma irradiation (4x2Gy) showed improved creatinine/urea/uric acid and preserved renal histology versus irradiated-only contro
Li J, Zhang L, Li Q, Zou Y, Ni Y, Kantapan J, Dechsupa N, Wang L
2026 · Tissue & cell
animal contradicts low In UUO and adenine-induced CKD/fibrosis mouse models, an engineered Iron-Quercetin metal-flavonoid complex (IronQ) decreased serum creatinine and BUN and reduced renal fibrosis markers (a-SMA, FN, Col1a1) via TGF-b1/Smad3/Egr1 inhibition. P
Akcakavak G, Akcakavak FK, Karatas O, Cifci AT, Kirgiz O, Kirgiz FC, Alakus H, Alakus I, Kenar ZC, Tuzcu M
2026 · Tissue & cell
animal contradicts moderate Rats given vancomycin 200 mg/kg IP twice daily x7d +/- quercetin 100 mg/kg oral: quercetin co-treatment increased antioxidants (SOD/CAT/GPx), reduced MDA and inflammatory/apoptotic markers, and preserved renal structure/function versus vanc
Zuo A, Li S, Xie J, Huang L, Li Z, Lin J, Zhao X, Wang M
2026 · International journal of molecular sciences
in-vitro contradicts low In diabetic (db/db) mice and TGF-b1-stimulated HK-2 human kidney cells, quercetin (identified as the principal bioactive component of the herbal formula Shen-Kang Recipe) bound SLC15A2/PEPT2 and suppressed epithelial-mesenchymal transition
Mahani FD, Heydari A, Sadeghian R, Alavi SS
2026 · Journal of biochemical and molecular toxicology
mechanism contradicts moderate Narrative review of natural compounds (curcumin, quercetin, baicalein) targeting ferroptosis in drug/toxin-induced nephrotoxicity (e.g., cisplatin, adriamycin): quercetin is described as enhancing protective GPX4/Nrf2 pathways to reduce kid
Feng X, Bu F, Huang L, Xu W, Wang W, Wu Q
2022 · European journal of pharmacology
animal contradicts moderate Meta-analysis of 20 rodent diabetic-nephropathy studies (378 animals, SYRCLE risk-of-bias assessed) found quercetin significantly improved renal index, urine protein, uric acid, urine albumin and serum creatinine (no significant effect on c
Zou C, Ye M
2026 · Dose-response : a publication of International Hormesis Society
animal contradicts moderate In a mouse model of renal ischemia-reperfusion (I/R) injury, quercetin alleviated renal injury and inflammation in vivo and reduced H2O2-induced inflammatory responses in NRK-52E kidney cells in vitro, by inhibiting the STING-NF-kB pathway
Wang X, Li W, Yuan W, Wei Z, Yang Z, Zhang Z, Sun Z, Ji G, Hu H
2026 · Life (Basel, Switzerland)
animal contradicts moderate In an iron-overload nephrotoxicity model (in vivo rodent + HK-2 cells in vitro), quercetin markedly reduced oxidative stress, iron accumulation and ferroptosis in renal tissue via Nrf2/xCT/GPX4 activation, attenuating renal injury. Protecti
Feng W, Zhou J, Zheng Y, Li Y
2026 · Pakistan journal of pharmaceutical sciences
animal contradicts moderate Mouse model of aconitine-induced renal interstitial fibrosis: high-dose quercetin reduced fibrotic area by ~60% (P<0.01) and suppressed PI3K/Akt-NE/NF-kB signaling versus model controls, in a low/medium/high-dose design. Protective, anti-fi
Li Z, Deng H, Guo X, Yan S, Lu C, Zhao Z, Feng X, Li Q, Wang J, Zeng J, Ma X
2022 · Phytomedicine : international journal of phytotherapy and phytopharmacology
animal contradicts moderate Systematic review/meta-analysis of 18 rodent studies (from 304 screened, methodological quality 7.06/10) found quercetin reduced Scr, BUN, urinary protein and improved renal pathology in diabetic-nephropathy models, with optimal effect at 9
Muzamil A, Tahir HM, Ali A
2026 · Toxicon : official journal of the International Society on Toxinology
animal contradicts moderate In mice, quercetin alone was safe up to 750 mg/kg with no toxicity noted, and quercetin (300-500 mg/kg, 83-100% survival) protected against Naja naja snake-venom-induced toxicity; treated kidneys showed no tubular degeneration versus venom
Wu M, Ye W, Ye X
2026 · Scientific reports
animal contradicts moderate In high-glucose-stressed mouse podocytes and a diabetic-nephropathy mouse model (high-fat diet + streptozotocin), the quercetin glycoside QODG reduced ferroptosis (lipid peroxidation, iron accumulation) via SIRT5-mediated TFR1 desuccinylati
Erdemli Z, Gul M, Bulut N, Zayman E, Demirtas S, Karaaslan E, Aylaz B, Bag HG, Erdemli ME
2026 · Journal of biochemical and molecular toxicology
animal contradicts moderate Wistar rats given tartrazine dye for 1 month developed nephrotoxicity (raised MDA/SOD/TOS/OSI, urea/uric acid/creatinine, histopathology, apoptosis); co-administered quercetin improved all of these biochemical and histopathological paramete
Yazdanpanah Z, Sobhani H, Navabi M, Jalali J, Ghasemzadeh Rahbardar M
2026 · Journal of biochemical and molecular toxicology
mechanism contradicts moderate Narrative review (2021-2025 literature) concludes quercetin is nephroprotective: lowers serum creatinine/urea, restores antioxidant enzymes (SOD/CAT/GPx), and reduces apoptosis/fibrosis via Sirt1/Nrf2/HO-1 and NF-kB pathways. No data presen

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.